Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. Antibodies
  4. Primary Antibodies
  5. All Primary Antibodies
  6. 502204007

IGHA2 Polyclonal Antibody, Abbomax

Catalog No. 502204007
Encompass_Preferred
Change view
Click to view available options
Quantity:
100 μg
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
50-220-4007 100 μg
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 50-220-4007 Supplier Abbomax Inc Supplier No. 601740
Add to Cart
Add to Cart

Description

Rabbit Polyclonal Antibody

Positive control: CCRF leukemia cells Cellular location: Cytoplasmic.

IGHA2 Polyclonal antibody specifically detects IGHA2 in Human samples. It is validated for ELISA, Immunohistochemistry (Paraffin), Western Blot

Specifications

Antigen IGHA2
Applications ELISA, Immunohistochemistry (Paraffin), Western Blot
Classification Polyclonal
Concentration 0.5 mg/mL
Conjugate Unconjugated
Formulation PBS with proprietary stabilizer and 0.01% sodium azide
Gene IGHA2
Gene Accession No. P01877
Host Species Rabbit
Immunogen A synthetic peptide corresponding to C-terminus of human IGHA2
Purification Method Antigen affinity chromatography
Quantity 100 μg
Regulatory Status RUO
Primary or Secondary Primary
Gene ID (Entrez) 3494
Target Species Human
Content And Storage Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.
Product Type Antibody
Form Liquid
Isotype IgG
Show More Show Less
Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.